3-[2-[(1S,5S,7S)-7-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl]-1H-quinazoline-2,4-dione
Modify Date: 2024-09-23 15:47:39
![3-[2-[(1S,5S,7S)-7-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl]-1H-quinazoline-2,4-dione Structure](https://image.chemsrc.com/caspic/495/208661-17-0.png)
3-[2-[(1S,5S,7S)-7-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl]-1H-quinazoline-2,4-dione structure
|
Common Name | 3-[2-[(1S,5S,7S)-7-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl]-1H-quinazoline-2,4-dione | ||
|---|---|---|---|---|
| CAS Number | 208661-17-0 | Molecular Weight | 379.427 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C22H22FN3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 3-[2-[(1S,5S,7S)-7-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl]-1H-quinazoline-2,4-dioneBelaperidone (LU-111995), a 5-HT2A receptor inhibitor, possesses antidopaminergic and antiserotonergic effects[1]. |
| Name | Belaperidone |
|---|---|
| Synonym | More Synonyms |
| Description | Belaperidone (LU-111995), a 5-HT2A receptor inhibitor, possesses antidopaminergic and antiserotonergic effects[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C22H22FN3O2 |
| Molecular Weight | 379.427 |
| Exact Mass | 379.169617 |
| LogP | 3.39 |
| Index of Refraction | 1.609 |
| 2,4(1H,3H)-Quinazolinedione, 3-[2-[(1S,5R,6S)-6-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl]- |
| 7566 |
| 4DN0TK4892 |
| (+)-3-(2-((1S,5R,6S)-6-(4-Fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl)ethyl)quinazoline-2,4(1H,3H)-dione |
| 3-{2-[(1S,5R,6S)-6-(4-Fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl}-2,4(1H,3H)-quinazolinedione |
| 3-{2-[(1s,5r,6s)-6-(4-fluorophenyl)-3-azabicyclo[3.2.0]hept-3-yl]ethyl}quinazoline-2,4(1h,3h)-dione |
| Belaperidone |